Latest information on COVID-19

Nasopharyngeal Cancer Program

Our mission is to provide comprehensive care and to conduct cutting edge research with a focus on translating discoveries from bench to bedside to help treat and cure individuals with nasopharyngeal cancer.

Call (650) 721-6509 for trial assistance

Our multidisciplinary group works together to care for patients throughout their treatment course for nasopharyngeal cancer, which is also known as nasopharynx cancer or nasopharyngeal carcinoma (NPC) of the head and neck. Our focus is on providing cutting-edge care for the best possible outcomes, including access to the latest diagnostics, treatments, and clinical trials, with a focus on each patient as an individual. The research from our group spans a spectrum from fundamental research to clinical applications. These research endeavors include basic science research to further our understanding of the underlying mechanisms of disease, fundamental engineering and bioengineering research to develop novel technologies for tumor imaging and treatment delivery, and development of clinical trials to investigate the latest targeted therapy and immunological approaches for the treatment of nasopharyngeal cancer patients.  We are dedicated to providing the best possible care to each patient now… and helping to establish the standards of practice for the future.